Bardoxolone-Methyl (CDDO-Me) Impairs Tumor Growth and Induces Radiosensitization of Oral Squamous Cell Carcinoma Cells
Radiotherapy represents a common treatment strategy for patients suffering from oral squamous cell carcinoma (OSCC). However, application of radiotherapy is immanently limited by radio-sensitivity of normal tissue surrounding the tumor sites. In this study, we used normal human epithelial keratinocy...
Saved in:
Main Authors: | Cornelius Hermann (Author), Simon Lang (Author), Tanja Popp (Author), Susanne Hafner (Author), Dirk Steinritz (Author), Alexis Rump (Author), Matthias Port (Author), Stefan Eder (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties
by: Wang YY, et al.
Published: (2014) -
Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells
by: Namrata Khurana, et al.
Published: (2020) -
Therapeutic effects of C-28 methyl ester of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO-Me; bardoxolone methyl) on radiation-induced lung inflammation and fibrosis in mice
by: Wang YY, et al.
Published: (2015) -
CDDO-Me alleviates oxidative stress in human mesenchymal stem cells
by: Hye Jin Cho, et al.
Published: (2021) -
Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells
by: Wang YY, et al.
Published: (2015)